Michael Berelowitz
Plus aucun poste en cours
Profil
Michael Berelowitz served as Senior Vice President & Head-Medicines Development at Pfizer Inc. from 2009 to 2011.
He also held director positions at American Diabetes Association, Endocrine Fellows Foundation, The Journal of Clinical Endocrinology & Metabolism, DIR Technologies Ltd., Oramed Pharmaceuticals, Inc., Kamada Ltd., Societal CDMO, Inc., and Cellect Biotechnology Ltd.
Additionally, he earned a doctorate degree from the University of Cape Town.
Anciens postes connus de Michael Berelowitz
| Sociétés | Poste | Fin |
|---|---|---|
| SOCIETAL CDMO, INC. | Directeur/Membre du Conseil | 17/05/2023 |
| KAMADA LTD. | Directeur/Membre du Conseil | 24/12/2019 |
| QUOIN PHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 06/08/2019 |
| ORAMED PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 30/08/2016 |
| Endocrine Fellows Foundation | Directeur/Membre du Conseil | 01/01/2015 |
Formation de Michael Berelowitz
| University of Cape Town | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| KAMADA LTD. | Health Technology |
| SOCIETAL CDMO, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
Cellect Biotechnology Ltd.
 Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. | Health Technology |
DIR Technologies Ltd.
 DIR Technologies Ltd. Medical SpecialtiesHealth Technology DIR Technologies Ltd. develops thermography based inspection solutions for pharmaceutical quality assurance and process control. The firm’s solutions include induction integrity verification system, heat sealing inspection and sachet full monitoring. The company was founded by Eran Sinbar and Yoav Weinstein in June 2009 and is headquartered in Haifa, Israel. ^ ^ ^ | Health Technology |
| Endocrine Fellows Foundation | |
The Journal of Clinical Endocrinology & Metabolism
 The Journal of Clinical Endocrinology & Metabolism Publishing: Books/MagazinesConsumer Services Part of The Endocrine Society, The Journal of Clinical Endocrinology & Metabolism provides medical journal services. | Consumer Services |
